Some investors are staying away from the market right now due to the volatility stocks have experienced this year and the ...

SINGAPORE] Over the five trading sessions from May 23 to May 29, institutions were marginal net sellers of Singapore stocks, ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

While vepdegestrant outperformed a standard treatment option in a subtype of patients, the benefit on progression-free ...

Detailed price information for Vertex Pharmaceutic (VRTX-Q) from The Globe and Mail including charting and trades.

Vertex Pharmaceuticals Inc. closed 14.97% short of its 52-week high of $519.88, which the company achieved on November 8th.

Cofounder John Donohue is stepping down on May 31 from his job as chief executive. He’ll still chair the company’s board and ...

Annual Secretarial Compliance - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and information in the form of graphs, charts, expert advice, and more to stay ...

UBS analyst Eliana Merle reaffirmed a Buy rating and a $582 price target for Vertex Pharmaceuticals, praising the adoption of ...

The AI agents mark a significant milestone as a direct outcome of the Google Cloud C enter of E xcellence, powered by Infosys Topaz™. The initiative leverages the advanced AI capabilities of Infosys ...

Vertex Pharmaceuticals is riding high on analyst confidence, thanks to its leadership in NAV1.8 inhibitors and smart partnerships. Jefferies analyst Michael Yee recently reaffirmed a Buy rating, ...

NRI PULSE STAFF REPORT Four Indian American women have secured prominent spots on Fortune’s 2025 Most Powerful Women in ...